by Sandra Annetzberger | Jul 25, 2022 | Uncategorized
An informative open access article was published on the current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. As one can tell from the article, the number of clincial trials for CAR-T multiple myeloma therapies is still rather low. While...
by Sandra Annetzberger | Jul 15, 2022 | Uncategorized
The 5th digital myeloma forum was a great success. On 9th July, the 5th edition of the Würzburg Myeloma Forum took place. With far more than 200 participants, mostly myeloma patients and their families as well as patient organisations, a large audience learned about...
by Sandra Annetzberger | Feb 24, 2022 | Uncategorized
CARAMBA AT THE 4th European CART Cell Meeting As in the recent years, CARAMBA was well presented at the 4th European CART Cell Meeting which took place as a fully virtual event this year (10-12 February 2022). The meeting was jointly organised by EHA and EBMT...
by Sandra Annetzberger | Sep 20, 2021 | Uncategorized
The CARAMBA Consortium published an article about the CARAMBA project. Within the article you can find information on CART cell technology and on the CARAMBA project. Supplemented by figures, the technology of virus-free gene transfer using the Spleeping Beauty...
by Sandra Annetzberger | Jul 2, 2021 | Uncategorized
In 2020, the two EU-projects CARAMBA and EURE-CART jointly organized a regulatory workshop on CAR-T cell development. With the EURE-CART project coming to an end in June 2021, the EURE-CART Consortium has now published a White Paper on CAR-T cell therapy development....
